A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants

NCT06342700 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Disorder
Healthy Volunteers

Interventions

DRUG: Rilzabrutinib crystalline form
DRUG: Rilzabrutinib amorphous form

Sponsor

Sanofi